Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection

Rodrigues, Tasson Costa; Oliveira, Maria Leonor Sarno de; Schanoski, Alessandra Soares; Rico, Stefanni Liliane Chavez; Figueiredo, Douglas Borges; Gonçalves, Viviane Maimoni; Ferreira, Daniela M; Kunda, Nitesh K; Saleem, Imran Y; Miyaji, Eliane Namie.
PLoS One ; 13(1): e0191692, 2018.
Artigo Inglês | SES-SP, SES SP - Instituto Butantan, SES-SP | ID: but-ib14956

Documentos relacionados

  1. Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection.
  2. Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection
  3. Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection
  4. Hepatitis E virus infection remodels the mature tRNAome in macrophages to orchestrate NLRP3 inflammasome response.
  5. Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcus.